Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA

Transfusion

Volumn 53, Issue 9, 2013, Pages 1956-1964

  Jakobsen, Tanja Roien ^a   Clausen, Frederik Banch ^a   Rode, Line ^a   Dziegiel, Morten Hanefeld ^a   Tabor, Ann ^a  

^a Rigshospitalet

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE FETAL DNA; DNA; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; FEMALE; FIRST TRIMESTER PREGNANCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

ADULT; DOWN SYNDROME; FEMALE; FETUS; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES;

EID: 84883852046     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12073     Document Type: Article

References (30)

1. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY,. Wiliams obstetrics. 23rd ed. Toronto: McGraw-Hill Professional; 2010.
2. Ness RB, Sibai BM,. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 40-49.
3. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS,. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
4. Hahn S, Rusterholz C, Hosli I, Lapaire O,. Cell-free nucleic acids as potential markers for preeclampsia. Placenta 2011; 32 (Suppl.): S17-S20.
5. Alberry MS, Maddocks DG, Hadi MA, Metawi H, Hunt LP, bdel-Fattah SA, Avent ND, Soothill PW,. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol 2009; 200: 98-6.
6. Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, Arraztoa JA, Michea L, Soothill PW,. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 2009; 29: 1118-1122.
7. Sifakis S, Zaravinos A, Maiz N, Spandidos DA, Nicolaides KH,. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol 2009; 201: 472-477.
8. Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF, Wataganara T, Romero R, Bianchi DW,. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004; 190: 707-713.
9. Clausen FB, Christiansen M, Steffensen R, Jorgensen S, Nielsen C, Jakobsen MA, Madsen RD, Jensen K, Krog GR, Rieneck K, Sprogøe U, Homburg KM, Grunnet N, Dziegiel MH,. Report of the first nationally implemented clinical routine screening for fetal RHD in D-pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012; 52: 752-758.
10. Anderson UD, Olsson MG, Kristensen KH, Akerstrom B, Hansson SR,. Review: biochemical markers to predict preeclampsia. Placenta 2012; 33: Suppl: S42-S47.
11. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME,. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004; 191: 1446-1451.
12. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH,. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005; 25: 949-953.
13. Danish Society of Obstetrics and Gynecology. Sandbjerg guidelines, 2012. [cited 2012 Jan 21]. Available from: URL: http://www.dsog.dk/sandbjerg/ 120403%20PIH%202012%20final.pdf
14. Clausen FB, Krog GR, Rieneck K, Rasmark EE, Dziegiel MH,. Evaluation of two real-time multiplex PCR screening assays detecting fetal RHD in plasma from RhD negative women to ascertain the requirement for antenatal RhD prophylaxis. Fetal Diagn Ther 2011; 29: 155-163.
15. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B,. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843-848.
16. Hahn S, Huppertz B, Holzgreve W,. Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta 2005; 26: 515-526.
17. Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS,. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011; 39: 641-652.
18. Roberts DJ, Post MD,. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008; 61: 1254-1260.
19. Chamley LW, Chen Q, Ding J, Stone PR, Abumaree M,. Trophoblast deportation: just a waste disposal system or antigen sharing? J Reprod Immunol 2011; 88: 99-105.
20. Kim JS, Romero R, Kim MR, Kim YM, Friel L, Espinoza J, Kim CJ,. Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histopathology 2008; 52: 457-464.
21. Redline RW,. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007; 38: 1439-1446.
22. Boog G,. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol 2008; 136: 9-15.
23. Redline RW,. Placental pathology: a systematic approach with clinical correlations. Placenta 2008; 29 (Suppl. A): S86-S91.
24. Tang Z, Abrahams VM, Mor G, Guller S,. Placental Hofbauer cells and complications of pregnancy. Ann N Y Acad Sci 2011; 1221: 103-108.
25. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y,. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116 (2 Pt 1): 402-414.
26. Roberge S, Giguere Y, Villa P, Nicolaides K, Vainio M, Forest JC, von, Dadelzen P, Vaiman D, Tapp S, Bujold E,. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012; 29: 551-556.
27. Choudhury M, Friedman JE,. Epigenetics and microRNAs in preeclampsia. Clin Exp Hypertens 2012; 34: 334-341.
28. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH,. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32: 732-739.
29. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH,. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009; 33: 23-33.
30. Vandenberghe G, Mensink I, Twisk JW, Blankenstein MA, Heijboer AC, van, Vugt JM,. First trimester screening for intra-uterine growth restriction and early-onset pre-eclampsia. Prenat Diagn 2011; 31: 955-961.